Marc Theoret

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Marc Theoret

Oct 23, 2024, 00:08 | Insight

Maryam Yazdy: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-cell Lymphomas

Maryam Yazdy, Senior Physician on the Lymphoma team in the Division of Hematologic Malignancies 2…

Jul 29, 2024, 13:24 | Insight

Gautam Mehta et al. summarize the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki - FDA Oncology

FDA Oncology shared a post on X about a paper titled "FDA approval summary: fam-trastuzumab…

Jul 19, 2024, 22:19 | Insight

Gautam Mehta summarizes the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki for HER2-mutated NSCLC

FDA oncology shared on X: "OCE's Gautam Mehta and colleagues summarize the FDA accelerated approval…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023